Preview Mode Links will not work in preview mode

Dec 13, 2022

Featuring an interview with Dr Omid Hamid, including the following topics:

  • First-line treatment of metastatic melanoma (0:00)
  • Triplet therapy for patients with BRAF-mutated metastatic melanoma (7:27)
  • Case: A man in his mid 60s with previously untreated BRAF wild-type metastatic melanoma (15:44)
  • Novel therapeutic strategies for patients with newly diagnosed melanoma (21:02)
  • Immunotherapy strategies for second-line treatment of metastatic melanoma (29:25)
  • Case: A man in his mid 40s with BRAF-mutated melanoma who experiences disease progression after treatment with ipilimumab and nivolumab (37:16)

CME information and select publications